Leslie Popplewell
City of Hope(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation
Most-Cited Works
- → CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma(2018)1,085 cited
- → Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study(2011)637 cited
- → Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans(2010)517 cited
- → Oral complications of cancer and cancer therapy(2012)516 cited
- → Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial(2021)500 cited
- → Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia(2015)346 cited
- → Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma(1998)333 cited
- → Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL(2016)327 cited
- → T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect(2003)247 cited
- → Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma(2010)216 cited